Clinton Calls Mylan EpiPen Price Hikes ‘Outrageous’
Mylan CEO Faces Calls to Explain 400% EpiPen Increase
Technical Indicators Flash Danger Signs for S&P 500 Bull: UBS
Yellen to Keep 2016 Rate Rise on Radar
These Charts Show Just How Quiet the Market Is Right Now

Most Popular

Whisky's Next Wave Is Lighter, Mellower, Made for Millennials
Watch This Surveillance Master Dissect a Murder From the Sky
How Employers May Be Shortchanging Your 401(k)